ArticleTranslational andrology and urology2016
Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses?
Article in Translational andrology and urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03824691 (Cabozantinib Plus Durvalumab in Patients With Advanced and Chemotherapy-treated Bladder Carcinoma, of Urothelial and Non-urothelial Histology), which is not on this map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Cabozantinib Plus Durvalumab in Patients With Advanced and Chemotherapy-treated Bladder Carcinoma, of Urothelial and Non-urothelial Histology: an Open-label, Single-centre, Phase 2, Single-arm Proof-of-concept Trial: ARCADIA Study
Who cites it
6 citing papers in PubMed.
- Metastasis development in non-muscle-invasive bladder cancer.Nature reviews. Urology · 2025Review
- Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.Cells · 2019Review
- The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder.World journal of urology · 2019Review
- The current role of circulating biomarkers in non-muscle invasive bladder cancer.Translational andrology and urology · 2019Review
- The landscape of genetics and biomarkers in bladder cancer.Translational andrology and urology · 2017Article
- The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer.Translational andrology and urology · 2017Review
Corrections and comments
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.